Methods of prognosing a rheumatoid arthritis remission phenotype

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8712696
APP PUB NO 20100087441A1
SERIAL NO

12309206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for prognosing a rheumatoid arthritis phenotype using the outcomes of selected single nucleotide polymorphisms (SNPs) and clinical variables. A method for genotyping multiple rheumatoid arthritis associated genetic variations comprising use of a DNA microrarray. A microarray for use in the described methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROGENIKA BIOPHARMA S APARQUE TECNOLOGICO DE BIZKAIA EDIFICIO 504 DERIO 48160

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Eguiara, Arrate Mondragón, ES 1 1
Martínez, Martínez Antonio Laukariz, ES 6 4
Simón, Buela Laureano San Sebasián, ES 8 9
Tejedor, Hernández Diego Mungia, ES 5 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 29, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00